Investigates the political and financial forces that have shaped AIDS research, including the growing dissension within scientific ranks, the power politics among virologists, and other controversial issues

We know that to err is human, but the HIV/AIDS hypothesis is one hell of a mistake. I say this rather strongly as a warning. Duesberg has been saying it for a long time. Read this book. --Kary B. Mullis, Nobel Prize in Chemistry, 1993

Despite enormous efforts, over 100,000 papers and over $22 billion spent by the US taxpayer alone, the HIV-AIDS hypothesis has failed to produce any public health benefits, no vaccine, no effective drug, no prevention, no cure, not a single life saved. Is the science system to be blamed? Has science failed to reveal the truth about AIDS? In AIDS: Virus or Drug Induced?, two dozen scientists, scholars and journalists have investigated the status quo of AIDS research. Most of them have questioned the HIV-AIDS hypothesis before, but have since been censored, and sociologically excluded from AIDS research, politics and journalism. Here they are united for the first time to put on trial the HIV-AIDS hypothesis. There are those who acquit HIV entirely. Others who make a case for HIV as a necessary, but not a sufficient cause of AIDS. And one medical scientist who, together with the huge AIDS literature, defends the hypothesis that HIV is sufficient to cause AIDS. The book convincingly reveals that the scientific method could very well find a solution to AIDS, but only if ideas can be exchanged freely and if the HIV monopoly can be broken. AIDS: Virus or Drug Induced? illustrates that the solution to AIDS could be as close as one of several, very testable and very affordable alternatives to the unproductive HIV-AIDS hypothesis.

"A former HIV researcher tells the story of her disillusionment with the HIV/AIDS hypothesis and exposes not only its numerous flaws but also problems with the scientific research establishment that enabled this hypothesis to take such a strong, hypnotic hold on the world at large"--Provided by publisher.

According to author Harvey Bialy, the work of molecular biologist Peter Duesberg has been grossly distorted by the media and scientific establishments. Until recently, the scientific community--and most notably, those from the National Institute for Health--have been unwilling to look at his provocative theories of different causes for cancer and HIV/AIDS. Inspired by UC Berkeley's rare creation of an archive for Duesberg's papers, this book explores Duesberg's early groundbreaking work with viruses and oncogenes, his contentious fights with other scientists, and the profound influence of his life's work.

A collection of 13 articles originally published in scientific journals between 1987 and 1995, that call into question the dogma of Infectious AIDS.

Society was not prepared in 1981 for the appearance of a new infectious disease, but we have since learned that emerging and reemerging diseases will continue to challenge humanity. AIDS at 30 is the first history of HIV/AIDS written for a general audience that emphasizes the medical response to the epidemic. Award-winning medical historian Victoria A. Harden approaches the AIDS virus from philosophical and intellectual perspectives in the history of medical science, discussing the process of scientific discovery, scientific evidence, and how laboratories found the cause of AIDS and developed therapeutic interventions. Similarly, her book places AIDS as the first infectious disease to be recognized simultaneously worldwide as a single phenomenon. After years of believing that vaccines and antibiotics would keep deadly epidemics away, researchers, doctors, patients, and the public were forced to abandon the arrogant assumption that they had conquered infectious diseases. By presenting an accessible discussion of the history of HIV/AIDS and analyzing how aspects of society advanced or hindered the response to the disease, AIDS at 30 illustrates for both medical professionals and general readers how medicine identifies and evaluates new infectious diseases quickly and what political and cultural factors limit the medical community’s response.